K092192 is an FDA 510(k) clearance for the WAYPOINT STEREOTACTIC SYSTEM. This device is classified as a Neurological Stereotaxic Instrument (Class II - Special Controls, product code HAW).
Submitted by FHC, Inc. (Bowdoin, US). The FDA issued a Cleared decision on February 12, 2010, 206 days after receiving the submission on July 21, 2009.
This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.4560.
| 510(k) Number | K092192 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | July 21, 2009 |
| Decision Date | February 12, 2010 |
| Days to Decision | 206 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | HAW - Neurological Stereotaxic Instrument |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 882.4560 |